1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Hormonal Therapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Market Perspective (2018-2029)
2.2 Prostate Cancer Growth Trends by Region
2.2.1 Prostate Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Market Dynamics
2.3.1 Prostate Cancer Industry Trends
2.3.2 Prostate Cancer Market Drivers
2.3.3 Prostate Cancer Market Challenges
2.3.4 Prostate Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Players by Revenue
3.1.1 Global Top Prostate Cancer Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Revenue
3.4 Global Prostate Cancer Market Concentration Ratio
3.4.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2022
3.5 Prostate Cancer Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Product Solution and Service
3.7 Date of Enter into Prostate Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Breakdown Data by Type
4.1 Global Prostate Cancer Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Breakdown Data by Application
5.1 Global Prostate Cancer Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Cancer Market Size (2018-2029)
6.2 North America Prostate Cancer Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Market Size (2018-2029)
7.2 Europe Prostate Cancer Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Market Size (2018-2029)
9.2 Latin America Prostate Cancer Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Astellas, Inc.
11.1.1 Astellas, Inc. Company Detail
11.1.2 Astellas, Inc. Business Overview
11.1.3 Astellas, Inc. Prostate Cancer Introduction
11.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2018-2023)
11.1.5 Astellas, Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Detail
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Prostate Cancer Introduction
11.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2018-2023)
11.2.5 AstraZeneca plc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Introduction
11.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Detail
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Prostate Cancer Introduction
11.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2018-2023)
11.4.5 Sanofi S.A Recent Development
11.5 Bristol Myers Squibb (BMS)
11.5.1 Bristol Myers Squibb (BMS) Company Detail
11.5.2 Bristol Myers Squibb (BMS) Business Overview
11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
11.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2018-2023)
11.5.5 Bristol Myers Squibb (BMS) Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Detail
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Prostate Cancer Introduction
11.6.4 Bayer AG Revenue in Prostate Cancer Business (2018-2023)
11.6.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
